SEC Comment Letter for Goosehead Insurance, (GSHD) — Apr 13, 2018
Goosehead Insurance, Inc.
Date: April 13, 2018 · CIK: 0001726978 · Accession: 0000000000-18-011271
AI Filing Summary & Sentiment
File numbers found in text: 333-224080
Letter
April 12, 2018 Mark E. Jones Chairman and Chief Executive Officer Goosehead Insurance, Inc. 1500 Solana Blvd. Building 4, Suite 4500 Westlake, Texas 76262 Re:Goosehead Insurance, Inc. Registration Statement on Form S-1 Filed April 2, 2018 Amendment No. 1 to Registration Statement on Form S-1 Filed April 5, 2018 File No. 333-224080 Dear Mr. Jones: We have reviewed your registration statement and amendment and have the following comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this comment, we may have additional comments. Amendment No. 1 to Form S-1 filed April 5, 2018 Executive Compensation Equity Compensation Plans Goosehead Insurance, Inc. Omnibus Incentive Plan, page 111 1.Please revise to disclose the vesting terms of the options you intend to grant upon the pricing of the offering.
FirstName LastNameMark E. Jones Comapany NameGoosehead Insurance, Inc. June 16, 2017 Page 2 FirstName LastName Mark E. Jones Goosehead Insurance, Inc. April 12, 2018 Page 2 We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. You may contact Rolf Sundwall at 202-551-3105 or Kevin Vaughn at 202-551-3494 if you have questions regarding comments on the financial statements and related matters. Please contact Chris Edwards at 202-551-6761 or Mary Beth Breslin at 202-551-3625 with any other questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Richard D. Truesdell, Jr.
Show Raw Text
April 12, 2018
Mark E. Jones
Chairman and Chief Executive Officer
Goosehead Insurance, Inc.
1500 Solana Blvd.
Building 4, Suite 4500
Westlake, Texas 76262
Re:Goosehead Insurance, Inc.
Registration Statement on Form S-1
Filed April 2, 2018
Amendment No. 1 to Registration Statement on Form S-1
Filed April 5, 2018
File No. 333-224080
Dear Mr. Jones:
We have reviewed your registration statement and amendment and have the following
comment.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to this comment, we may have additional comments.
Amendment No. 1 to Form S-1 filed April 5, 2018
Executive Compensation
Equity Compensation Plans
Goosehead Insurance, Inc. Omnibus Incentive Plan, page 111
1.Please revise to disclose the vesting terms of the options you intend to grant upon the
pricing of the offering.
FirstName LastNameMark E. Jones
Comapany NameGoosehead Insurance, Inc.
June 16, 2017 Page 2
FirstName LastName
Mark E. Jones
Goosehead Insurance, Inc.
April 12, 2018
Page 2
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
You may contact Rolf Sundwall at 202-551-3105 or Kevin Vaughn at 202-551-3494 if
you have questions regarding comments on the financial statements and related matters. Please
contact Chris Edwards at 202-551-6761 or Mary Beth Breslin at 202-551-3625 with any other
questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Richard D. Truesdell, Jr.